Real Life Evaluation of Rheumatoid Arthritis Patients in Israel Treated With HUMIRA

Trial Profile

Real Life Evaluation of Rheumatoid Arthritis Patients in Israel Treated With HUMIRA

Withdrawn prior to enrolment
Phase of Trial: Phase IV

Latest Information Update: 22 Feb 2016

At a glance

  • Drugs Adalimumab (Primary)
  • Indications Rheumatoid arthritis
  • Focus Therapeutic Use
  • Acronyms ORIENT
  • Sponsors AbbVie
  • Most Recent Events

    • 17 Feb 2016 Planned End Date changed from 1 Nov 2019 to 1 Feb 2020 as reported by ClinicalTrials.gov record.
    • 17 Feb 2016 Planned primary completion date changed from 1 Nov 2019 to 1 Feb 2020 as reported by ClinicalTrials.gov record.
    • 17 Feb 2016 Status changed from not yet recruiting to withdrawn prior to enrolment as reported by ClinicalTrials.gov record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top